News and Insights of 3D Printing and Manufacturing
American multinational consumer goods company Procter & Gamble (P&G) has signed a 3D bioprinting research and development agreement with San Francisco biotechnology company Aether.
ROKIT Healthcare, a Korean 3D bioprinter manufacturer previously known as ROKIT, has introduced a novel 3D bioprinting method to treat scarred lesions.
Researchers at St. Mary’s Hospital in Seoul, South Korea, have applied 3D printing to the treatment of a condition that can cause respiratory problems and sleep disorders. In a clinical study, the team used 3D printing to develop a biocompatible splint that could be inserted into the nose and help correct a deviated septum. In 20 volunteer patients, aged 18-74, the 3D printed device proved to outperform other artificial splints.
Swedish 3D bioprinter manufacturer CELLINK has agreed to acquire the in-vitro technology specialist MatTek Corporation for $68 million.
Researchers from the University of Wollongong (UOW) ARC Centre of Excellence for Electromaterials Science (ACES) in Australia, have developed a customizable 3D bioprinter, 3D Alek, to combat congenital ear deformity.
Scientists from the Foundation for Research and Science Development in Poland (Fundacja Badań I Rozwoju Nauki or Fundacja BIRN) are using 3D bioprinting to create a bionic pancreas.
CELLINK, the Swedish manufacturer of the BIO X 3D printer, and Volumetric a Texas-based biomaterials and biomanufacturing company, have introduced the Lumen X Digital Light Processing (DLP) bioprinter to produce large vascular structures.
South Korean scientists are working to improve cancer treatments with 3D bioprinting.
Philadelphia-headquartered 3D bioprinting company Allevi has launched the Skin Bioink Kit. A material package, this kit is to be used in conjunction with its 3D bioprinters to produce patches of skin. It aims to allow tissue engineers to design multi-layered skin patches that are more akin to natural human skin.
Scientists from the University at Buffalo have developed a rapid new 3D bioprinting method that could represent a significant step towards fully-printed human organs.